immune response


Also found in: Dictionary, Thesaurus, Medical, Legal, Acronyms, Wikipedia.
Related to immune response: humoral immune response

immune response

[i′myün ri‚späns]
(immunology)
The physiological responses stemming from activation of the immune system by antigens, consisting of a primary response in which the antigen is recognized as foreign and eliminated, and a secondary response to subsequent contact with the same antigen.
References in periodicals archive ?
When they were give 50 mg a day-way above USRDA levels but still quite safe-tor replenish all their vitamin B-6 stores, their immune responses were boosted over the levels they had before they entered the study.
We have elected to focus on the use of mice largely because for this species there is a sophisticated appreciation of the immune response, coupled with the availability of a range of reagents.
It's a risky business to block immune response to HIV as a therapeutic measure,' notes William Paul of the National Institute of Allergy and Infectious Diseases in Bethesda, Md.
Eric Rosenberg and Bruce Walker of Massachusetts General Hospital, shows that all of the people in their study who took Remune developed strong anti HIV immune responses during a planned treatment interruption, while none of the people who only took antiviral medicine developed these responses.
A role for monomeric antibodies in the mucosal immune response.
The Immune Response Corporation is a biopharmaceutical company engaged in the development of proprietary products for the treatment of HIV infection and autoimmune diseases and products utilizing gene therapy, antisense and drug delivery technology.
As a result, the Th-1 immune response is completely abrogated and the specific Th-1 response to HIV is selectively eliminated.
This later phase of the immune response depends upon so-called T and B cells.
There are several biological reasons for believing that an immune response directed against Tat (or possibly Gag) may be particularly effective in controlling HIV.
In addition, Immune Response intends to begin Phase I gene therapy trials utilizing the company's patented gene delivery technology by year-end 1996.
The Immune Response Corporation (OTCBB:IMNR), an immuno-pharmaceutical company focused on developing products to treat autoimmune diseases and HIV/AIDS, announced today that it will make a one-for-100 reverse stock split of its common stock.